Lumedica was founded by an experienced team of engineers including Chief Scientist Dr. Adam Wax from the Pratt School of Engineering. Dr. Wax’s team has developed a new low-cost optical coherence tomography (OCT) scanner that could dramatically extend the impact of the imaging technology for eye health by making eye imaging more affordable, accessible and easier to use. Affordable access would enable more health care providers to conduct OCT imaging, giving patients greater, earlier access to the one test that can save their vision and improve their quality of life.
“I’ve worked with OTC on many technologies over the years. They’ve helped me develop the patent protection we needed to get our companies off the ground.” – Adam Wax, PhD, Professor of Biomedical Engineering, Pratt School of Engineering
New space for biomedical engineering research
[Originally posted by Duke Magazine— June 12, 2018]
When Adam Wax A.M. ’96, Ph.D. ’99, president and chief scientist of Lumedica, has a question about the basic science behind the design of the affordable, cutting-edge biomedical imaging machines Lumedica makes, sometimes he needs to go back to his lab at Duke, where he’s professor of biomedical engineering.
The journey covers exactly one stairway.
The Lumedica lab lives on the third floor of the Chesterfield, on Main Street in downtown Durham, which had its grand opening in December 2017. Lumedica got its creative start in Wax’s research in his lab in the Fitzpatrick Center for Interdisciplinary Engineering, Medicine, and Applied Sciences (FCIEMAS) on West Campus. It grew to the point where it needed its own lab space, which it now rents from BioLabs North Carolina, a wet-lab coworking space that occupies the second and third floors of the newly renovated Chesterfield. Duke itself rents space on the fourth floor, where Wax recently opened up a new lab as part of his work as a Duke professor, though he still keeps the machines whirring and the postdocs thinking in his biomedical interferometry optics and spectroscopy lab back at FCIEMAS.
Seems like a lot of moving parts? Welcome to the future of biomedical engineering and research. Welcome to the Chesterfield.